The global antisense therapy market benefits from advances in drug delivery, including targeted conjugates designed to improve delivery to selected tissues. Such technologies can help address a major development challenge: ensuring that sufficient amounts of an antisense medicine reach the intended cells. The antisense therapy market was valued at US$ 6.17 billion in 2025 and is projected to...